BIOCRYST PHARMACEUTICALS, INC. Shares Outstanding (Cover Page)
BIOCRYST PHARMACEUTICALS, INC. (BCRX) had Shares Outstanding (Cover Page) of 255.54 million shares as of 2026-07-31, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-05
- 2026-07-31: Entity Common Stock, Shares Outstanding 255.54M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 254.16M shares.
- 2026-02-20: Entity Common Stock, Shares Outstanding 250.80M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 210.54M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 255.54M shares 10-Q · filed 2026-08-05 |
| 2026-04-30 | 254.16M shares 10-Q · filed 2026-05-06 |
| 2026-02-20 | 250.80M shares 10-K · filed 2026-02-26 |
| 2025-10-31 | 210.54M shares 10-Q · filed 2025-11-04 |
| 2025-07-31 | 209.92M shares 10-Q · filed 2025-08-05 |
| 2025-04-30 | 209.25M shares 10-Q · filed 2025-05-06 |
| 2025-02-20 | 208.96M shares 10-K · filed 2025-02-25 |
| 2024-10-31 | 207.13M shares 10-Q · filed 2024-11-05 |
| 2024-07-31 | 206.89M shares 10-Q · filed 2024-08-06 |
| 2024-04-30 | 206.38M shares 10-Q · filed 2024-05-07 |
| 2024-02-23 | 206.15M shares 10-K · filed 2024-02-27 |
| 2023-10-31 | 204.81M shares 10-Q · filed 2023-11-08 |
| 2023-07-28 | 189.49M shares 10-Q · filed 2023-08-07 |
| 2023-04-28 | 188.93M shares 10-Q · filed 2023-05-08 |
| 2023-01-31 | 188.45M shares 10-K · filed 2023-02-27 |
| 2022-10-31 | 186.42M shares 10-Q · filed 2022-11-04 |
| 2022-07-29 | 185.95M shares 10-Q · filed 2022-08-05 |
| 2022-04-29 | 185.58M shares 10-Q · filed 2022-05-09 |
| 2022-01-31 | 184.66M shares 10-K · filed 2022-02-28 |
| 2021-10-29 | 179.94M shares 10-Q · filed 2021-11-04 |
| 2021-07-30 | 178.87M shares 10-Q · filed 2021-08-09 |
| 2021-04-30 | 177.70M shares 10-Q · filed 2021-05-07 |
| 2021-01-31 | 177.18M shares 10-K · filed 2021-03-01 |
| 2020-10-31 | 176.57M shares 10-Q · filed 2020-11-06 |
| 2020-07-31 | 176.57M shares 10-Q · filed 2020-08-07 |
| 2020-04-30 | 154.25M shares 10-Q · filed 2020-05-11 |
| 2020-01-31 | 154.19M shares 10-K · filed 2020-03-13 |
| 2019-10-31 | 110.44M shares 10-Q · filed 2019-11-08 |
| 2019-07-31 | 110.44M shares 10-Q · filed 2019-08-08 |
| 2019-04-30 | 110.31M shares 10-Q · filed 2019-05-09 |
| 2019-01-31 | 110.18M shares 10-K · filed 2019-03-14 |
| 2018-10-31 | 109.64M shares 10-Q · filed 2018-11-08 |
| 2018-07-31 | 98.93M shares 10-Q · filed 2018-08-09 |
| 2018-04-30 | 98.72M shares 10-Q · filed 2018-05-09 |
| 2018-01-31 | 98.61M shares 10-K · filed 2018-03-12 |
| 2017-10-31 | 98.40M shares 10-Q · filed 2017-11-08 |
| 2017-07-31 | 80.43M shares 10-Q · filed 2017-08-08 |
| 2017-04-30 | 80.42M shares 10-Q · filed 2017-05-08 |
| 2017-01-31 | 73.96M shares 10-K · filed 2017-02-27 |
| 2016-10-31 | 73.76M shares 10-Q · filed 2016-11-08 |
| 2016-07-31 | 73.70M shares 10-Q · filed 2016-08-08 |
| 2016-04-30 | 73.69M shares 10-Q · filed 2016-05-09 |
| 2016-01-31 | 73.58M shares 10-K · filed 2016-02-26 |
| 2015-10-31 | 73.34M shares 10-Q · filed 2015-11-06 |
| 2015-07-31 | 73.24M shares 10-Q · filed 2015-08-07 |
| 2015-04-30 | 72.52M shares 10-Q · filed 2015-05-08 |
| 2015-01-31 | 72.32M shares 10-K · filed 2015-03-02 |
| 2014-10-31 | 71.86M shares 10-Q · filed 2014-11-07 |
| 2014-07-31 | 71.76M shares 10-Q · filed 2014-08-08 |
| 2014-04-30 | 60.06M shares 10-Q · filed 2014-05-09 |
| 2014-01-31 | 59.38M shares 10-K · filed 2014-03-10 |
| 2013-10-31 | 59.09M shares 10-Q · filed 2013-11-08 |
| 2013-07-31 | 54.24M shares 10-Q · filed 2013-08-08 |
| 2013-04-30 | 53.15M shares 10-Q · filed 2013-05-09 |
| 2013-01-31 | 50.93M shares 10-K · filed 2013-03-11 |
| 2012-10-31 | 50.88M shares 10-Q · filed 2012-11-08 |
| 2012-07-31 | 50.49M shares 10-Q · filed 2012-08-08 |
| 2012-04-30 | 49.17M shares 10-Q · filed 2012-05-08 |
| 2012-01-31 | 46.04M shares 10-K · filed 2012-03-06 |
| 2011-11-01 | 45.21M shares 10-Q · filed 2011-11-03 |
| 2011-08-01 | 45.15M shares 10-Q · filed 2011-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |